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Background: Diabetes is associated with cognitive decline or dementia. The purpose of this study was to assess
the executive functions and information processing in patients with type 2diabetes in comparison to pre-diabetic
patients and normal subjects in Endocrine and Metabolism Research Center of Isfahan City from April to July 2011.
Methods: The sample consisted of 32 patients with type 2 diabetes, 28 pre-diabetic patients and 30 healthy individuals.
Executive functions were assessed by Wisconsin Card Sorting Test (WCST). Information processing was assessed by
Paced Auditory Serial Addition Test (PASAT) and sub tests of Wechsler Adult Intelligence Scale-Revised (WAIS-R).
Results: There was a significant difference among 3 groups, after the variables of age, sex and academic status were
controlled (p ≤ 0.001). The pairwise comparisons of executive functions among three groups suggest a significant
difference between diabetic and normal groups in WCST (perseveration) p = 0.018, and significant difference between
diabetic and pre-diabetic patient in WCST (perseveration) p = 0.019. But there was no difference between three groups
in WCST (category) and WCST (conceptual responses). The pairwise comparisons of information processing among
three groups, suggest a significant difference between diabetic and normal groups in PASAT3”. PASAT2”, and Symbol
coding (P = 0.003, P = 0.009, and P = 0.001, respectively). There was a significant correlation between demographic
variable (FBS, HbA1c) and Symbol coding p = 0.05, p = 0.01 respectively) and significant correlation between
(cholesterol) and WCST (conceptual responses) p = 0.05. The other variables were not correlated.
Conclusion: There were significant differences in executive function and information processing in patients with type 2
diabetic and normal individuals. Thus, monitoring neuropsychological status besides controlling levels of blood sugar in
these patients is important.
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Several reports have indicated that diabetes may cause cog-
nitive dysfunction [1-3] or an alternation in brain signals re-
lated to cognitive function [4-6] and accelerated cognitive
decline [7,8]. Recent epidemiological studies suggest that
diabetes mellitus is a stronger risk factor for Alzheimer dis-
ease [9-13]. Patient with diabetes mellitus show increased
progression of brain atrophy [2,14]. Several research studies
following large groups over many years suggest that adults* Correspondence: m1ahmad2000@gmail.com
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distribution, and reproduction in any mediumwith type 2 diabetes have a higher risk of later developing
Alzheimer′s, and the risk effects are stronger when diabetes
occurs mid life than in late life [15]. Previous studies have
shown decrement in executive functions and information
processing [16-18]. The stage of cognitive decrements is
not manifested and may occur in pre- diabetic stage. Pre-
diabetes period is the stage of impaired glucose regulation,
or blood sugar levels that are higher than normal but not
yet in the diabetic range. Insulin resistance (pre-diabetes
period) may be maker of Alzheimer disease associated
with reduced cognitive impairment at the earliest of
disease, even before the onset of mild cognitiventral Ltd. This is an open access article distributed under the terms of the
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play an important role in preserving cognitive perform-
ance among patient with type 2 diabetes. In patients with
type 2 diabetes, studies have demonstrated an inverse rela-
tionship between serum Hb1Ac and working memory, ex-
ecutive functioning, learning and complex psychomotor
performance. This finding supports the hypothesis that an
inadequate glucose control is associated with worsening
cognitive function [19]. The few studies that have been
conducted on pre-diabetic period [18] and also a study
performed on the patients indicated that patients in pre-
diabetic period experience decline in memory functioning
[10]. But there was no significant difference in other types
of performance such as attention and visual-spatial function
[10]. According to the importance of the variable in studies
and the fact that some functions such as executive function
and information processing are not measured in this study,
we intend to investigate executive and information process-
ing functioning in diabetic and pre-diabetic patients.
Methods
This study was a cross-sectional one which was started
in April 2011 and ended in July 2011 in Endocrine and
Metabolism center of Isfahan city. Sample size was 32
for diabetes, 28 for pre-diabetes, and 30 for normal sub-
jects. Diabetic and pre-diabetic patients were selected
after the diagnosis made by a specialist according to
American Diabetes Association criteria for diagnosis,
and also according to their clinical data recorded in their
files. Correlation coefficients between the research vari-
ables and the demographic variables including age, sex
and academic status were controlled by the researcher.
The inclusion criteria for entering the study were: being
diabetic or pre-diabetic according to the diagnosis made
by a specialist, age range between 35 to 60 years, being
educated (from grade 9 and up). Clients had to have nor-
mal or corrected vision and hearing sufficient to adequately
comprehend the test instruction and to discriminate
visually the stimulus parameters of color, form, number
and finally have no depression. Psychiatric interview
was conducted according to DSM-TV-R for screening
depression by MSc in clinical psychology. The control
group was matched with the experimental groups, and
selected from the personnel of University of Isfahan,
and from personnel of some elementary schools. The
patients were selected randomly according to the
research criteria. The criteria for diagnosis of diabetes
according to American Diabetes Association is fasting
plasma glucose (FPG) at or above 126 mg/dL (7.0 mmol/L),
at 2-h value in an oral tolerance test (OGGT) at or
above 200 mg/dL (11/1 mmol/L) and if plasma glucose
test is greater than 126 mg/dL, one might have im-
paired fasting glucose (IFG). Some people also have im-
paired glucose tolerance (IGT), a condition in whichblood glucose levels are higher than normal (140 mg/dL
to 199 mg/dc) 2 hours after the start of an oral glucose
tolerance test (GTT) if one has IFG and or IGT, one
may be diagnosed with pre-diabetes American Diabetes
Association, 2005 [20].
Written consent was taken from each patient, and they
were interviewed by the researcher for not being clinically
depressed. Then, all of the three groups were assessed by
executive function tests. Other clinical and demographic
data were obtained from each patient’s files.
Executive functional assessment
Wisconsin Card Sorting Test (WCST): the purpose of
this test is to assess the ability to form abstract concept,
shift and maintain set, and utilize feedback. This test
was designed to assess abstraction ability and the ability
to shift cognitive strategies in response to changing
environmental contingencies. The test is considered to
measure executive function. The perseveration responses
of this test reveal an ability to relinquish the old category
for the new one, or the inability to see a new possibility.
Category gives an indication of initial conceptualization,
in turn, reflecting the concentration of perseveration er-
rors in relation to overall test performance [21]. The
interrater reliability of this test is 0.83 and test -retest of
this test is 0.74 [22]. The reliability of this test has been
reported to be about 0.85 [23].
Information processing assessment
1. Tests of Symbol Coding from the Wechsler Adult
Intelligence Scales-Revised (WAIS-R) test battery
[24]. This sub test was used to assess information
processing. Test –retest reliability of the test, is
reported to be 0.90 [25].
2. Paced Auditory Serial Addition Test (PASAT).
This test is a serial addition task used to assess rate
information processing and attention [21]. The
reliability of this test was 0.90. The reliability of the
test was calculated by the authors of this article. The
calculated Cronbach's alpha was 0.74.
Statistical analysis
1. Shapiro - Wilk and Kolgomorov Smirnov tests were
used to test normality for data, and in some data the
Kruskal-Wallis test was used instead of parametric
statistical tests. Also, Leven test was used in order to
test equality of variances. There was equality of vari-
ances for the result of symbol coding, however, there
haven't been seen equality of variances for Paced
Auditory Serial Addition Test (PASAT), therefore, in
addition to ANCOVA, the non parametric test was
also done for the data.
Table 2 Results of multivariate analysis of variance in










Age 0.87 1.88 0.09 0.12 0.66
Gender 0.77 3.91 0.002 0.22 0.95
Education 0.60 8.45 0.0001 0.39 1
Group 0.65 3.11 0.001 0.19 0.99
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results of WCST (perseveration); however, there
were no equality of variances for WCST (conceptual
responses) and WCST (category), hence, in addition
to ANCOVA, the non parametric tests were also
applied to the data.
3. Since the authors have used analysis of covariance
for the data, first of all the correlations between
executive function, information processing and
demographic variables (age, education and gender)
were calculated, and then those variables with
significant effects were controlled; and finally the
analysis of covariance was used in order to find
possible differences between executive function in
three groups.
Results
Table 1 shows median and standard deviation in demo-
graphic variables (education and age) in three groups
diabetes, pre- diabetes and normal subjects. As well as
shows median and standards deviation in clinical vari-
ables (HbA1c, FBS, 2hpp and cholesterol) in patients
with diabetes and pre- diabetes groups. As can be seen,
the mean age of diabetic group is more and greater than
the mean age of control and pre diabetics, so we can
concluded that diabetes may associate with aging. There
were no significant differences in educational level of
three groups.
According to Table 2, there was a significant difference
among 3 groups, after the variables of age; sex and aca-
demic status (p ≤ 0.001) were controlled. Eta square
shows that 19% of the difference in executive function
can be due to the difference among three groups.Table 1 demographic and clinical characteristics of 3
groups
Group Mean Std. deviation N
Age diabetes type 2 50.43 6.53 32
Pre-diabetes 48.46 6.66 28
Control group 44.93 6.10 30
Education diabetes type 2 12.31 2.38 32
Pre-diabetes 12.35 1.96 30
Control group 12.74 2.38 28
HbA1c diabetes type 2 7.51 2.01 30
Pre-diabetes 5.26 0.55 28
FBS diabetes type 2 165.0 84.17 30
Pre-diabetes 110.9 14.56 28
2hpp diabetes type 2 228.1 86.93 30
Pre-diabetes 134.5 46.56 28
Cholesterol diabetes type 2 172.3 35.87 30
Pre-diabetes 183.9 50.49 28According to Table 3, there was a significant correl-
ation between demographic variable (FBS, HbA1c) and
Symbol coding (p = 0.05, p = 0.01 respectively) and sig-
nificant correlation between (cholesterol) and WCST
(conceptual responses) p = 0.05. The other variables
were not correlated.
According to Table 4, the difference in information pro-
cessing among three groups was statistically significant for
PASAT3” (P = 0.012), PASAT2” (P = 0.033 and symbol
coding (P = 0.001). The difference in executive functions
among three groups was statistically significant for WCST
(perseveration) p = 0.025 but not for WCST p = 0.35 and
WCST (conceptual responses) p = 0.28.
Table 5 shows the pairwise comparisons of informa-
tion processing among three groups, suggesting a sig-
nificant difference between diabetic and normal groups
in PASAT3”. PASAT2”, and Symbol coding (P = 0.003,
P = 0.009, and P = 0.001, respectively). There was a sig-
nificant difference between pre-diabetic group and normal
group between diabetes type 2 and pre-diabetic group in
symbol coding (P = 0.001), and the pairwise comparisons
of executive functions among three groups, suggesting aTable 3 Correlation coefficient and significant coefficient
of research variables in 2 groups, diabetes type 2 and
pre-diabetes
Research variables FBS HbA1c Cholesterol
PASAT3” Correlation 0.18 −0.20 0.16
Sig 0.16 0.13 0.27
PASAT2” Correlation 0.16 −0.14 0.20
Sig 0.21 0.27 0.17
WCST (conceptual responses) Correlation −0.11 0.13 0.17*
Sig 0.41 0.33 0.04
WCST (perseveration) Correlation 0.20 0.12 −0.20
Sig 0.88 0.36 0.30
WCST (category) Correlation 0.20 0.12 −0.20
Sig 0.88 0.36 0.30
Symbol coding Correlation 0.25* 0.38** 0.05
Sig 0.05 0.004 0.70
**Correlation is significant at the 0.01 level. *Correlation is significant at the
0.05 level.
Table 4 Results of multivariate analysis of covariate in patients with type 2 diabetes, pre-diabetes and control group
Independent variable Variable Sumof square df Sig Partial Eta squared Observed power
Group
PASAT3” 705.78 2 0.01 0.10 0.77
PASAT2” 399.62 2 0.03 0.07 0.64
WCST (perseveration) 179.985 2 0.025 0.084 0.68
WCST (category) 4.546 2 0.35 0.24 0.22
Symbol coding 1865.52 2 0.0001 0.24 0.99
WCST (conceptual responses) 15.274 2 0.25 0.032 0.28
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in WCST (perseveration) p = 0.018, and significant differ-
ence between diabetic and pre-diabetic patient in WCST
(perseveration) p = 0.019. But there was no difference be-
tween three groups in WCST (category) and WCST (con-
ceptual responses).
As seen in Figure 1, the mean- adjusted indicated that
the score of control group in executive functions and in-
formation processing assessments are significantly more
and higher than both diabetics and pre-diabetic patients.
Discussion
The results of this study show that there was a signifi-
cant difference among normal, diabetic and pre-diabetic
groups in executive function of WCST (perseveration)
and information processing. In other word the perform-
ance of diabetic group was lower than the other two
groups. Wateriet et al. [26] in their studies report that
there was a significant difference between diabetic and
control group in their information processing andTable 5 Results of pairwise comparisons in patients with type
Dependent variable Groups
WCST (perseveration) type 2 diabetes Pre
No
Pre-diabetes No
WCST (category) type 2 diabetes Pre
No
Pre-diabetes No
WCST (conceptual responses) type 2 diabetes Pre
No
Pre-diabetes No
PASAT3” type 2 diabetes Pre
No
Pre-diabetes No
PASAT2” type 2 diabetes Pre
No
Pre-diabetes No
Symbol Coding type 2 diabetes Pre
No
Pre-diabetes Noexecutive functions, which is similar to the result of this
study. This finding is concordant with the reports of
Berg et al. [16] and Elderen et al. [2]. Roriz et al. [19] in a
review article concluded that type 2 diabetes is strongly
associated with functioning of the brain and diabetes
type 2 increases memory deficit and reduces executive
functions and information processing. As some recent
researches have shown, there is a possibility of a rela-
tionship between Alzheimer disease and diabetes [2], and
even between pre-diabetics and Alzheimer, as well [18].
Baker et al. [13] reported that there might be a relation-
ship between insulin resistance (per-diabetic period) and
deterioration of an Alzheimer type. One of the important
purposes of this study was to determine whether pre-
diabetic patients show a significant difference in informa-
tion processing and executive functions, in comparison to
normal group? There was no difference among them in
the information processing and executive functioning.
Ruis et al. [18] in their research reported that patients at
early stage of diabetes type 2 becomes significantly worse2 diabetes, pre-diabetes and normal group
Mean Std. error Sig
-diabetic 3.005 1.25 0.019
rmal 3.146 1.30 0.018
rmal 0.141 1.301 0.914
-diabetic −0.360 0.386 0.55
rmal −0.566 0.401 0.162
rmal -.206 0.399 0.608
-diabetic −0.595 0.615 0.336
rmal −1.051 0.638 0.103
rmal -.451 0.635 0.474
-diabetic −4.011 2.26 0.07
rmal −7.13 2.35 0.003
rmal −3.01 2.34 0.20
-diabetic −2.30 1.95 0.24
rmal −5.40 2.03 0.009
rmal −3.09 2.02 0.12
-diabetic −7.39 2.16 0.001
rmal −11.44 2.24 0.0001
rmal −4.04 2.22 0.07
Figure 1 Estimate margin of executive functioning. A: WCST (perseveration), B: WCST (category) and C: WCST (conceptual responses), and
Estimate margin of information processing (D: pasat3″, E: pasat 2, F: symbol coding, in patient type 2 diabetes, pre-diabetes and control group.
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attention and executive functioning, but the mean differ-
ences between the group were small, and other research
conducted on pre-diabetic patients showed that a pre-diabetic patient becomes worse in memory functioning
than normal subjects [10]. The results of our study have
shown that there was no difference in information pro-
cessing and executive functioning in per-diabetic patients
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cant difference in information processing and executive
functions in patient with type 2 diabetes. The similarity
between our results and other researches ‘again emphasize
on the cognitive deficits which are evident in diabetic pa-
tients. Another finding of this study was that there is a sig-
nificant relationship between HbA1c and FBS and some
demographics and with WCST (perseveration) in diabetes,
which is similar to Yaffe et al. [27]. Our research is a
cross- sectional and not longitudinal study; in hence the
duration of disease has not been studied. In some studies,
possible mild cognitive deterioration have been shown in
pre-diabetic stages as revealed in Ruis et al. [18] and
Nazaribadie et al. [10] in other cognitive performances
such as memory and executive functions. People with im-
paired glucose tolerance – the precursor to Type 2 dia-
betes – often show impaired cognitive function that may
be alleviated through a diet designed specifically for their
condition. Impaired glucose tolerance is a pre-diabetic
state of hyperglycemia that is associated with insulin re-
sistance and a higher risk of cardiovascular disease. It can
precede Type 2 diabetes by several years, and some life-
style changes, such as getting to a healthy weight and in-
creasing exercise, can help pre-diabetic people avoid that
progression completely.
In summary, cognitive decrement can be found in
diabetic stage. This finding may have implication for
diabetic education and self management in diabetic pa-
tients. All of these studies show that the possible link
between executive deterioration and diabetes might be
serious, and future researches should open a new way
in our understanding of the possible related factors.
The prominent innovation of this study was that it
was carried out on a sample of pre diabetic patients for
the first time. Several limitations of the present study
should be considered. First, our study did not analyze
the effects of duration of diabetes type 2 and pre-
diabetes.The second limitation of this study was that the
level of literacy of the patients was supposed to be more
than second year of secondary school, however, the liter-
acy of some patients were lower than that. A third limi-
tation was that, Executive functions are very complex
cognitive domain, and our tools (wisconsin card sorting
test) only measure abstraction and set shifting but this
test is a gold standard in measuring this fields and
widely used around the worlds.
Conclusion
In conclusion, these findings suggest that diabetic pa-
tients experience decline in executive functioning. Thus,
monitoring neuropsychological status besides controlling
levels of blood sugar in these patients is important. In
this study, some aspects of cognition in patients with
diabetes were reviewed. To fully explore the cognitiveimpairments in people with diabetes, Further studies are
recommended.
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